Skip to main content

Table 1 Comparison of clinicopathological parameters in women who received radiation stratified by EZH2 expression

From: EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer

Prognostic factors EZH2 negative EZH2 positive  
Number of patients Percent Number of patients Percent P value
Age of diagnosis (N = 62)
 ≥ 45 11 68.75 29 63.04 0.77
 < 45 5 31.25 17 39.96
Race (N = 59)
 Non-Hispanic White 15 93.75 33 76.74 0.26
 All others 1 6.25 10 23.26
Lymph node status (N = 60)
 Negative 3 18.75 4 9.09 0.23
 Positive 13 81.25 40 90.91
Histologic type (N = 62)
 Ductal 12 75.0 42 91.30 0.19
 Others 4 25.0 4 8.70
Lymphovascular invasion (N = 56)
 No 4 26.67 5 12.20 0.23
 Yes 11 73.33 36 87.80
ER expression (N = 61)
 Negative 1 6.67 33 71.74 < 0.0001
 Positive 14 93.33 13 28.26
PR expression (N = 61)
 Negative 8 53.33 34 73.91 0.19
 Positive 7 46.67 12 26.09
HER2 expression (N = 61)
 Negative 11 73.33 28 60.87 0.54
 Positive 4 26.67 18 39.13
Triple-negative status (N = 61)
 No 15 100.00 30 65.22 0.005
 Yes 0 0.00 16 34.78
Radiation type (N = 62)
 Preoperative 1 6.25 6 13.04 0.66
 Postoperative 15 93.75 40 86.96
BID radiation (N = 48)
 No 0 0.00 10 26.32 0.09
 Yes 10 100.00 28 73.68
Radiation dose (N = 48) Dose   Dose  
  11 67.09 37 63.47 0.03